Antibiotic cloth before surgery to prevent esophagus infection
Part of Cancer, Digestive system clinical trials.
This Phase 3 trial tests whether using an antibiotic decolonization treatment around the time of esophagus surgery can reduce serious infections afterward. It may help you lower the risk of postoperative infectious complications after curative esophagectomy or esophagus reconstruction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign informed consent in writing
- You have esophageal cancer (adenocarcinoma or squamous cell cancer) in the mid/distal esophagus or near the stomach-esophagus junction, and you’re scheduled for curative esophagus surgery
- Your surgery plan is a transthoracic esophagectomy or reconstruction using stomach or small-bowel tissue (not colon)
- You are not currently planning an emergency “rescue” surgery
- You can understand the study and follow study instructions, including swallowing the study product if required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares different “treatments before surgery” for people with esophageal (or esophagus-to-stomach) cancer. It aims to see which approach works better to control the cancer and improve outcomes after surgery.
This trial tests whether combining immunotherapy with chemotherapy before surgery can help treat adenocarcinoma of the esophagus and stomach junction. It aims to improve outcomes for patients whose cancer can be surgically removed.
This study tests a new pre-surgery treatment plan that combines chemotherapy with focused, shorter-course radiation for esophagus or stomach-where-it-meets-the-esophagus (GEJ) adenocarcinoma. The goal is to shrink the tumor before surgery and improve treatment outcomes.
This study tests a combination of two drugs (a type of immunotherapy called adebrelimab and an immune-boosting drug called thymalfasin) given with chemotherapy before surgery for esophageal cancer. The goal is to see if this approach can shrink the tumor and improve the chances of a successful surgery.
This trial tests a special bandage that uses a gentle electric charge to help prevent infections in surgical wounds. If you are having planned colon surgery for diverticulitis, polyps, or colon cancer, and you meet certain health requirements, you may be able to join.
This study tests whether removing a certain mouth germ (P. gingivalis) with a common antibiotic can improve recovery and outcomes after esophageal cancer surgery. It is for people who recently had their cancer removed and are not getting radiation.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.